Chinese medicine injection wins the highest award of China's intellectual property rights for the first time

Recently, the Chinese patent award ceremony, known as the "Oscar" of China's intellectual property industry, was held in Beijing Kangyuan Pharmaceutical Invention Patent "a drug for clearing heat and detoxifying and its preparation method" recommended by Jiangsu Intellectual Property Office won the gold medal of the 15th China Patent Award, which is also the first time that the patent of traditional Chinese medicine injection won the gold medal of China Patent Award The purpose of the China patent award is to recognize the patentees, inventors and designers who have made outstanding contributions to actively using the intellectual property system, promoting technological innovation and promoting economic and social development Nearly 800 excellent projects have been recommended by the relevant departments of the State Council, national industry associations, academicians of the two academies and all provinces, districts and cities in China, with a record number of projects participating in the evaluation After the evaluation by the State Intellectual Property Office and the world intellectual property organization, 20 projects of China Patent Gold Award and 336 projects of China Patent Excellence Award were awarded Kangyuan pharmaceutical Reduning Injection stands out in many recommended projects and wins the gold medal of China patent award with its scientific and technological strength and product innovation It is understood that after years of intensive research, Reduning injection was launched in 2005 and became the first new Chinese medicine injection approved after the implementation of the 2005 version of the measures for the administration of drug registration After the launch of Reduning injection, Kangyuan pharmaceutical continued to study the material basis, mechanism and quality control of the product The results showed that the chemical structure of Reduning injection was more than 75% and the measurable components were more than 85% The antiviral and anti-inflammatory active components and mechanism were basically defined by combining the network pharmacology method and the experimental verification in vitro and in vivo Kangyuan pharmaceutical attaches great importance to the quality control of the whole process of the production of Reduning injection It has established a quality control system for the whole process of production, including 16 fingerprints, 247 quality monitoring projects and 460 SOPs It is the first approved traditional Chinese medicine injection controlled by the standard of fingerprints in China Research shows that Reduning injection can fight against EV71, H1N1, H5N1, H3N2, h7n9 and other viruses, and it has been listed in the national emergency reserve for influenza prevention and control, the national medical insurance catalog, the guidelines for the diagnosis and treatment of hand, foot and mouth disease, the diagnosis and treatment plan for influenza A (H1N1), and the diagnosis and treatment plan for human infection with h7n9 avian influenza by the Ministry of health It will play an active role in promoting the development of Chinese traditional medicine injection The head of Kangyuan pharmaceutical industry said that it would take this opportunity to continue to increase investment in new drug research and development and intellectual property protection, so as to develop and produce more national drug products for the people.